|
- Age-Related Macular Degeneration (AMD) - National Eye Institute
Age-related macular degeneration (AMD) is an eye disease that can blur your central vision It happens when aging causes damage to the macula — the part of the eye that controls sharp, straight-ahead vision
- Strategy to prevent age-related macular degeneration identified
A new National Eye Institute-supported study identifies a possible way to slow or block progression of age-related macular degeneration (AMD), a leading cause of blindness in people over age 50
- NEI Research News - National Eye Institute
A new National Eye Institute-supported study identifies a possible way to slow or block progression of age-related macular degeneration (AMD), a leading cause of blindness in people over age 50
- Age-Related Macular Degeneration: Status of Research
The National Eye Institute is making strides toward researching the cause of and developing treatments for age-related macular degeneration while ensuring judicious use of Federal research dollars
- New research offers hope for preventing age-related blindness
By examining genes associated with both AMD and rarer inherited forms of blindness called macular dystrophies, the researchers identified a key protein involved in the early stages of the disease
- American Macular Degeneration Foundation - National Eye Institute
The American Macular Degeneration Foundation is a non-profit organization committed to the prevention, treatment, and cure of macular degeneration The AMDF offers hope and support to those with Age-related Macular Degeneration (AMD) and their families
- Age-Related Macular Degeneration: What You Should Know
Download a booklet that provides information about age-related macular degeneration (AMD) and answers questions about its causes, symptoms, stages, and treatment
- Clinical Trial Highlight: Stem Cell Transplants for Dry AMD
Age-related macular degeneration (AMD) is a leading cause of vision loss among people 55 years old and older There is no treatment for geographic atrophy (GA), the advanced stage of dry AMD, in which cells of the retina and associated retinal pigment epithelium (RPE) gradually degenerate and die
|
|
|